| Batch Notification Number |
BN-OL-2022-08-04-4025
|
| FDA Registered Product/Generic Name |
Co-Amoxiclav
|
| Brand Name |
NATRAVOX
|
| Dosage Strength |
642.9 mg/ 5 mL
|
| Dosage Form |
Powder for Oral Suspension
|
| Registration Number |
DR-XY36416
|
| Batch Number |
22NS608
|
| Lot Number |
N/A
|
| Product Expiration Date |
Jul 2024
|
| Issuance Date |
5 August 2022
|